By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept
Cover of Sidekick Health’s whitepaper on FDA’s 2023 draft guidance for Prescription Drug Use-Related Software (PDURS), exploring digital health innovation in Life Sciences across therapeutic areas such as oncology, cardiometabolic conditions, and dermatology.image placeholder

New FDA Guidance On PDURS Ushers In A New Era for Digital Innovation In Life Sciences

This deep dive explores how the FDA’s draft PDURS guidance enables pharma companies to integrate digital solutions into their products, enhancing patient engagement and adherence. We cover the opportunities this brings for improving patient outcomes, how PDURS supports value-based healthcare, and the role of digital tools in creating a competitive edge in a crowded market.

by
Emilia Kruzel, PhD and Brooke Mastrorio
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Download PDF
Oops! Something went wrong while submitting the form.
you may also like
placeholder image
DTx User Acquisition Strategies: Best Practices for Market Access
Download PDF
placeholder image
Optimizing Cancer Care with Sidekick’s Human-Centric Digital Therapeutics Program
Download PDF
Cover of Sidekick Health’s whitepaper on FDA’s 2023 draft guidance for Prescription Drug Use-Related Software (PDURS), exploring digital health innovation in Life Sciences across therapeutic areas such as oncology, cardiometabolic conditions, and dermatology.placeholder image
New FDA Guidance On PDURS Ushers In A New Era for Digital Innovation In Life Sciences
Download PDF